Dr. David Alberts
Add to your Care-Team
Dr. David Alberts
Dr. David Alberts
Internal Medicine - Oncology
I specialize in
Internal Medicine - Oncology
I have been in practice
My answers and insights have
Helped 20 people
Here are kind words from others
This Thanksgiving, I wanted to share my appreciation for all that you do! Thank you, doctor! :)
I was educated and trained at
Medical / Graduate School
University of Virginia School of Medicine
Difluoromethylornithine: the proof is in the polyamines.
Cancer Prev Res (Phila)., Dec;5(12):1341-4 (2012)
Health Care Expenditures, Hospitalizations, and Productivity Associated With Cancer in US Employer Settings.
J. Occup. Environ. Med., Dec;54(12):1453-60 (2012)
Design and Baseline Characteristics of Participants in a Phase III Randomized Trial of Celecoxib and Selenium for Colorectal Adenoma Prevention.
Cancer Prev Res (Phila)., Dec;5(12):1381-93 (2012)
Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study.
Gynecol. Oncol., Dec;127(3):451-5 (2012)
Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma: Evaluation of potential chemopreventive activity.
Cancer., Dec;118(23):5848-56 (2012)
Loss of heterozygosity at the glutathione peroxidase 1 locus is not an early event in colon carcinogenesis.
Genes Cancer., Sep;2(9):910-3 (2011)
Karyometry of nuclear phenotypes in cutaneous squamous cell cancer.
Anal. Quant. Cytol. Histol., Feb;34(1):1-8 (2012)
Investigation of bendamustine HCL in a Phase 2 study in women with resistant ovarian cancer.
Invest New Drugs., May (2012)
Phase I trial of intraperitoneal pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian cancer.
Clin. Cancer Res., May;18(9):2668-78 (2012)
Functional protein pathway activation mapping of the progression of normal skin to squamous cell carcinoma.
Cancer Prev Res (Phila)., Mar;5(3):403-13 (2012)
Karyometry in atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
Gynecol. Oncol., Apr;125(1):129-35 (2012)
Risk modification of colorectal adenoma by CYP7A1 polymorphisms and the role of bile acid metabolism in carcinogenesis.
Cancer Prev Res (Phila)., Feb;5(2):197-204 (2012)
Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.
Cancer Prev Res (Phila)., Nov;4(11):1761-9 (2011)
A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometryâ˜†
Urol. Oncol., Jul (2011)
Colorectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesions.
Clin Colorectal Cancer., Dec;10(4):310-6 (2011)
Nuclear morphometry identifies a distinct aggressive cellular phenotype in cutaneous squamous cell carcinoma.
Cancer Prev Res (Phila)., Nov;4(11):1770-7 (2011)
p38 MAP kinase plays a functional role in UVB-induced mouse skin carcinogenesis.
Mol. Carcinog., Jun;50(6):469-78 (2011)
Pilot study of the prospective identification of changes in cognitive function during chemotherapy treatment for advanced ovarian cancer.
J Support Oncol., 8(6):252-8 (2010 Nov-Dec)
Current academic clinical trials in ovarian cancer: Gynecologic Cancer Intergroup and US National Cancer Institute Clinical Trials Planning Meeting, May 2009.
Int. J. Gynecol. Cancer., Oct;20(7):1290-8 (2010)
Dose response of retinol and isotretinoin in the prevention of nonmelanoma skin cancer recurrence.
Nutr Cancer., 62(8):1058-66 (2010)
Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer.
Clin. Cancer Res., Nov;16(21):5320-8 (2010)
Loss of inositol polyphosphate 5-phosphatase is an early event in development of cutaneous squamous cell carcinoma.
Cancer Prev Res (Phila)., Oct;3(10):1277-83 (2010)
Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study.
Cancer Prev Res (Phila)., Sep;3(9):1168-75 (2010)
Chemopreventive efficacy of topical difluoromethylornithine and/or triamcinolone in the treatment of actinic keratoses analyzed by karyometry.
Anal. Quant. Cytol. Histol., Dec;31(6):355-66 (2009)
Quercetin potentiates UVB-Induced c-Fos expression: implications for its use as a chemopreventive agent.
Cancer Prev Res (Phila)., Jul;3(7):876-84 (2010)
Diet and survival after ovarian cancer: where are we and what's next?
J Am Diet Assoc., Mar;110(3):366-8 (2010)
Chemotherapy resistance as a predictor of progression-free survival in ovarian cancer patients treated with neoadjuvant chemotherapy and surgical cytoreduction followed by intraperitoneal chemotherapy: a Southwest Oncology Group Study.
Oncology., 77(6):395-9 (2009)
A phase 2a study of topical perillyl alcohol cream for chemoprevention of skin cancer.
Cancer Prev Res (Phila)., Feb;3(2):160-9 (2010)
Sulindac and sulindac metabolites in nipple aspirate fluid and effect on drug targets in a phase I trial.
Cancer Prev Res (Phila)., Jan;3(1):101-7 (2010)
Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer: final survival results of a SWOG (S0200) phase 3 randomized trial.
Gynecol. Oncol., Mar;116(3):323-5 (2010)
Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients.
Cancer Prev Res (Phila)., Dec;2(12):1023-30 (2009)
Estimation of colorectal adenoma recurrence with dependent censoring.
BMC Med Res Methodol., 9:66 (2009)
Knowledge discovery processing and data mining in karyometry.
Anal. Quant. Cytol. Histol., Jun;31(3):125-36 (2009)
Karyometry: correction algorithm for differences in staining.
Anal. Quant. Cytol. Histol., Apr;31(2):63-73 (2009)
Physical activity as a determinant of fecal bile acid levels.
Cancer Epidemiol. Biomarkers Prev., May;18(5):1591-8 (2009)
Chemoprevention of human actinic keratoses by topical DL-alpha-tocopherol.
Cancer Prev Res (Phila)., Apr;2(4):394-400 (2009)
Progression of skin lesions from normal skin to squamous cell carcinoma.
Anal. Quant. Cytol. Histol., Feb;31(1):17-25 (2009)
Vitamin D, calcium, and colorectal neoplasia: new insights on mechanisms of action.
Cancer Prev Res (Phila)., Mar;2(3):197-9 (2009)
Analysis of colorectal adenoma recurrence data subject to informative censoring.
Cancer Epidemiol. Biomarkers Prev., Mar;18(3):712-7 (2009)
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup.
J. Clin. Oncol., Mar;27(9):1419-25 (2009)
A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy.
Gastroenterology., Mar;136(3):832-41 (2009)
Actinic damage in histopathologically normal skin.
Anal. Quant. Cytol. Histol., Dec;30(6):316-22 (2008)
Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009.
Gynecol. Oncol., Mar;112(3):444-9 (2009)
Digital image analysis of breast epithelial cells collected by random periareolar fine-needle aspirates (RPFNA) from women at high risk for breast cancer taking hormone replacement and the aromatase inhibitor, letrozole, for six months.
Breast Cancer Res. Treat., Jun;115(3):661-8 (2009)
Retinol, vitamins, and cancer prevention: 25 years of learning and relearning.
J. Clin. Oncol., Dec;26(34):5495-6 (2008)
Limits of detection of chemopreventive efficacy: karyometry of skin biopsies.
Cancer Epidemiol. Biomarkers Prev., Jul;17(7):1689-95 (2008)
Factors associated with osteonecrosis of the jaw among bisphosphonate users.
Am. J. Med., Jun;121(6):475-483.e3 (2008)
Phase 1 study of topical perillyl alcohol cream for chemoprevention of skin cancer.
Nutr Cancer., 60(3):325-30 (2008)
The nutritional prevention of cancer: 400 mcg per day selenium treatment.
Nutr Cancer., 60(2):155-63 (2008)
Vitamin D insufficiency in southern Arizona.
Am. J. Clin. Nutr., Mar;87(3):608-13 (2008)
Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: results from a prospectively designed analysis of prog
Gynecol. Oncol., May;109(2):174-81 (2008)
Plasma insulin-like growth factor I is inversely associated with colorectal adenoma recurrence: a novel hypothesis.
Cancer Epidemiol. Biomarkers Prev., Feb;17(2):300-5 (2008)
Cross-validation of murine UV signal transduction pathways in human skin.
Photochem. Photobiol., 84(2):463-76 (2008 Mar-Apr)
Karyometry of the colonic mucosa.
Cancer Epidemiol. Biomarkers Prev., Dec;16(12):2704-16 (2007)
Using optical coherence tomography to evaluate skin sun damage and precancer.
Lasers Surg Med., Oct;39(9):687-95 (2007)
Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwest Onc
Gynecol. Oncol., Jan;108(1):90-4 (2008)
Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression.
Cancer., Dec;110(11):2519-27 (2007)
An early signal of CA-125 progression for ovarian cancer patients receiving maintenance treatment after complete clinical response to primary therapy.
J. Clin. Oncol., Aug;25(24):3615-20 (2007)
Meat intake, preparation methods, mutagens and colorectal adenoma recurrence.
Carcinogenesis., Sep;28(9):2019-27 (2007)
Modulation of human glutathione s-transferases by polyphenon e intervention.
Cancer Epidemiol. Biomarkers Prev., Aug;16(8):1662-6 (2007)
Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study.
Gynecol. Oncol., Nov;107(2):260-5 (2007)
Association between body size and colorectal adenoma recurrence.
Clin. Gastroenterol. Hepatol., Aug;5(8):982-90 (2007)
Karyometry of breast epithelial cells acquired by random periareolar fine needle aspiration in women at high risk for breast cancer.
Anal. Quant. Cytol. Histol., Apr;29(2):63-70 (2007)
Cyclooxygenase 2 expression in cervical intraepithelial neoplasia and vulvar cancer.
J Low Genit Tract Dis., Apr;11(2):80-5 (2007)
The role of intraperitoneal therapy in advanced ovarian cancer.
Oncology (Williston Park, N.Y.)., Feb;21(2):227-32; discussion 232, 235, 239-42 (2007)
Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211).
Int. J. Gynecol. Cancer., 17(4):784-8 (2007 Jul-Aug)
Serum 25(OH)D levels, dietary intake of vitamin D, and colorectal adenoma recurrence.
J. Steroid Biochem. Mol. Biol., Mar;103(3-5):752-6 (2007)
Maximizing the delivery of intraperitoneal therapy while minimizing drug toxicity and maintaining quality of life.
Semin. Oncol., Dec;33(6 Suppl 12):S8-17 (2006)
Effects of repeated green tea catechin administration on human cytochrome P450 activity.
Cancer Epidemiol. Biomarkers Prev., Dec;15(12):2473-6 (2006)
Cancer chemoprevention and cancer preventive vaccines--a call to action: leaders of diverse stakeholder groups present strategies for overcoming multiple barriers to meet an urgent need.
Cancer Res., Dec;66(24):11540-9 (2006)
Risk group, skin lesion history, and sun sensitivity reliability in squamous cell skin cancer progression.
Cancer Epidemiol. Biomarkers Prev., Nov;15(11):2292-7 (2006)
Dietary factors and biomarkers involved in the methylenetetrahydrofolate reductase genotype-colorectal adenoma pathway.
Gastroenterology., Dec;131(6):1706-16 (2006)
Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer.
Gynecol. Oncol., Dec;103(3):783-92 (2006)
Second cancers are killing us!
Cancer Epidemiol. Biomarkers Prev., Nov;15(11):2019 (2006)
Reproducibility and expression of skin biomarkers in sun-damaged skin and actinic keratoses.
Cancer Epidemiol. Biomarkers Prev., Oct;15(10):1841-8 (2006)
Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.
Cancer Epidemiol. Biomarkers Prev., Aug;15(8):1443-50 (2006)
Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrence.
Int. J. Cancer., Sep;119(6):1440-6 (2006)
Pretreatment CA-125 and risk of relapse in advanced ovarian cancer.
J. Clin. Oncol., Mar;24(9):1454-8 (2006)
Fiber, sex, and colorectal adenoma: results of a pooled analysis.
Am. J. Clin. Nutr., Feb;83(2):343-9 (2006)
The evolution of scanning microphotometry: a historical review.
Anal. Quant. Cytol. Histol., Dec;27(6):323-36 (2005)
Tirapazamine plus cisplatin in advanced or recurrent carcinoma of the uterine cervix: a Southwest Oncology Group study.
Int. J. Gynecol. Cancer., 16(1):298-305 (2006 Jan-Feb)
Adherence assessment using medication weight in a phase IIb clinical trial of difluoromethylornithine for the chemoprevention of skin cancer.
Cancer Epidemiol. Biomarkers Prev., Nov;14(11 Pt 1):2579-83 (2005)
Karyometry of infiltrating breast lesions.
Anal. Quant. Cytol. Histol., Aug;27(4):195-201 (2005)
Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial.
Int. J. Cancer., Apr;118(7):1777-81 (2006)
MGMT promoter methylation and field defect in sporadic colorectal cancer.
J. Natl. Cancer Inst., Sep;97(18):1330-8 (2005)
Randomized trial of adjuvant intraperitoneal alpha-interferon in stage III ovarian cancer patients who have no evidence of disease after primary surgery and chemotherapy: An intergroup study.
Gynecol. Oncol., Jan;100(1):133-8 (2006)
Introduction: what should we do now about H. pylori?
Cancer Epidemiol. Biomarkers Prev., Aug;14(8):1851-2 (2005)
Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.
Clin. Cancer Res., Jun;11(12):4627-33 (2005)
Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.
J. Natl. Cancer Inst., Jun;97(11):846-53 (2005)
In vitro drug resistance versus chemosensitivity: two sides of different coins.
J. Clin. Oncol., May;23(15):3641-3; author reply 3646-8 (2005)
Diet and biomarkers of oxidative damage in women previously treated for breast cancer.
Nutr Cancer., 51(2):146-54 (2005)
Fatty acid composition of red blood cell membranes and risk of squamous cell carcinoma of the skin.
Cancer Epidemiol. Biomarkers Prev., Apr;14(4):906-12 (2005)
Second order discriminant analysis in chemopreventive efficacy measurement.
Anal. Quant. Cytol. Histol., Feb;27(1):15-26 (2005)
Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers.
Hum. Pathol., Mar;36(3):242-9 (2005)
What happened to the coxibs on the way to the cardiologist?
Cancer Epidemiol. Biomarkers Prev., Mar;14(3):555-6 (2005)
Exploratory study of ovarian intraepithelial neoplasia.
Cancer Epidemiol. Biomarkers Prev., Feb;14(2):299-305 (2005)
Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial.
Gynecol. Oncol., Mar;96(3):721-8 (2005)
Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group.
Gynecol. Oncol., Mar;96(3):610-5 (2005)
Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials.
Semin. Oncol., Dec;31(6 Suppl 13):53-90 (2004)
Dr. David Alberts M